Citation Impact
Citing Papers
Vitamin D Deficiency and Risk of Cardiovascular Disease
2008 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
2015 Standout
Injectable antibacterial conductive nanocomposite cryogels with rapid shape recovery for noncompressible hemorrhage and wound healing
2018 Standout
Thiazolidinediones
2004 Standout
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
2009
Designing and developing a literature-derived, population-based dietary inflammatory index
2013 Standout
Treatment of insulin resistance in diabetes mellitus
2004
Anti-inflammatory activity of natural dietary flavonoids
2010 Standout
REVIEW: Plasminogen Activator Inhibitor‐1 (PAI‐1): A Key Factor Linking Fibrinolysis and Age‐Related Subclinical and Clinical Conditions
2010
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Inflammation: the link between insulin resistance, obesity and diabetes
2003 Standout
A Clinical Prediction Model to Estimate Risk for 30-Day Adverse Events in Emergency Department Patients With Symptomatic Atrial Fibrillation
2010
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
Oral Anticoagulant Therapy
2012 Standout
Body composition and fat repartition in relation to structure and function of large arteries in middle-aged adults (the SU.VI.MAX study)
2005
Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
2003
Allostatic load biomarkers of chronic stress and impact on health and cognition
2009 Standout
C‐Reactive Protein (CRP)‐Lowering Agents
2006
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Prevention of VTE in Nonsurgical Patients
2012 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Obesity
2005 Standout
Pleiotropic functions of plasminogen activator inhibitor-1
2004
Calorie restriction and aging: review of the literature and implications for studies in humans
2003
Putting cardiovascular disease and vitamin D insufficiency into perspective
2005
Coagulation and fibrinolysis abnormalities in obesity
2002
Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: A model for type 2 diabetes and pharmacological screening
2005 Standout
Seasonal Variation in Serum Cholesterol Levels
2004
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies
2006 Standout
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1
2004
Thrombogenic alleles, Escherichia coli O157:H7 infections, and hemolytic uremic syndrome
2001
Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine
2008 Standout
Hepatic insulin resistance, metabolic syndrome and cardiovascular disease
2009
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Treatment Strategies for Acute Ischemic Stroke Caused by Carotid Artery Occlusion
2016 Standout
Allostatic Load, Perceived Stress, and Health: A Prospective Study in Two Age Groups
2004
Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: Role of drug induced homocysteinemia?
2007
Adipose Tissue as an Endocrine Organ
2004 Standout
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
DNA methylation GrimAge strongly predicts lifespan and healthspan
2019 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Adipose Tissue, Inflammation, and Cardiovascular Disease
2005 Standout
Effects of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate, on thrombus formation and bleeding time in rats
2007
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
2010 Standout
Regulation of Plasma PAI-1 Concentrations in HAART-Associated Lipodystrophy During Rosiglitazone Therapy
2003
Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin
2013
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke
2005
Triggering of Acute Cardiovascular Disease and Potential Preventive Strategies
2006
Pathophysiology of Type 2 Diabetes Mellitus
2020 Standout
Relation of Nonalcoholic Hepatic Steatosis to Early Carotid Atherosclerosis in Healthy Men
2004
Predictors of Early Arterial Reocclusion After Tissue Plasminogen Activator-Induced Recanalization in Acute Ischemic Stroke
2005
Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation
2006
Differential Pattern of Tissue Plasminogen Activator–Induced Proximal Middle Cerebral Artery Recanalization Among Stroke Subtypes
2004
From Estrogen-Centric to Aging and Oxidative Stress: A Revised Perspective of the Pathogenesis of Osteoporosis
2010 Standout
Arterial Aging
2005
Binding of Tissue-Plasminogen Activator to Fibrin: Effect of Ultrasound
1998
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
The Metabolic Syndrome
2008 Standout
Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism
2013 Standout
Development of a Point of Care Lateral Flow Device for Measuring Human Plasma Fibrinogen
2010 StandoutNobel
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Nontraditional Risk Factors for Cardiovascular Disease in Diabetes
2004
Plasma PAI-1 Levels Are More Strongly Related to Liver Steatosis Than to Adipose Tissue Accumulation
2003
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.
1998 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Works of Mojca Stegnar being referenced
Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss
2001
Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors
2004
Seasonal variation of some metabolic and haemostatic risk factors in subjects with and without coronary artery disease
2001
Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models
2005
High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy
2003
Impact of Weight Reduction on Early Carotid Atherosclerosis in Obese Premenopausal Women
2001
Lysing Patterns of Retracted Blood Clots with Diffusion or Bulk Flow Transport of Plasma with Urokinase into Clots – a Magnetic Resonance Imaging Study In Vitro
1992
The 4G/5G Sequence Polymorphism in the Promoter of Plasminogen Activator Inhibitor-1 (PAI-1) Gene: Relationship to Plasma PAI-1 Level in Venous Thromboembolism
1998